CRISPR–Cas12-based detection of SARS-CoV-2James P. Broughton, Charles Y. Chiu, Xianding Deng et al.|Nature Biotechnology|2020Cited by 2.8k
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactionsDaniel Butler, Christopher E. Mason, Peter A.D. Steel et al.|Nature Communications|2021Cited by 189
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discoveryJessica Karielle Tan, Charles Y. Chiu, Venice Servellita et al.|Nature Communications|2024Cited by 48
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 EnzymeClare L. Fasching, Charles Y. Chiu, Venice Servellita et al.|Journal of Clinical Microbiology|2022Cited by 44
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsVenice Servellita, Charles Y. Chiu|medRxiv|2022Cited by 23